The second Exeltis Day scientific conferences are being held today and tomorrow in Valencia, bringing together over 300 gynaecologists to examine the latest developments in gynaecology
This will also be the stage where the preliminary findings of the FLEXO study will be presented, assessing the impact of information about contraception
New technologies and social media in gynaecology will be some of the current issues discussed during these days
Its plant in Azuqueca de Henares, Liconsa, has been acclaimed for its commitment to innovation and investment in cutting-edge technologies
The Director of Pharma Operations, José Prieto, was presented with the award by the President of Castilla-La Mancha, Emiliano García Page
Liconsa recently received other awards for its importance and contribution to the Castilla-La Mancha region
The selected projects are an immunobiogram for the treatment of inflammatory diseases, a device for urinary incontinence and a non-invasive artificial pancreas for diabetes
Each project, depending on its characteristics, will receive mentoring and coaching, as well as funding and investment to develop the proposal
The ultimate aim of the #ChemoStart programme is to promote the creation of start-ups that revolutionise and improve people's health
The programme created to promote start-ups specialising in innovative solutions for patients will hold its pitch day today
Today, seven entrepreneurs selected as finalists will defend their projects before a panel of top industry experts
The winning projects will be given mentoring, coaching, co-working spaces and financial support according to the project
8 November 2017 | Geneva −− The World Health Organization (WHO) and the Mundo Sano Foundation are working to make an essential antiparasitic medicine for treatment of Chagas disease widely accessible to children. Treatment with benznidazole in the early stages of infection can cure the Chagas disease, but currently very few people are able to access diagnosis and treatment services.
This investment will help the inventor of the IUB™ intrauterine platform to boost its expansion and increase manufacturing capacity
Chemo Group is already marketing the spherical copper intrauterine device in several European countries
Chemo India Formulations located in Hyderabad, have required an initial investment of around ₹100 crores (USD 16 million)
Specialized in the development and manufacture of oral solid dosage forms, including tablets, caplets, hard gelatin capsules and pellets
On August 29th, the U.S. Food and Drug Administration (FDA) approved Chemo Research’s New Drug Application (NDA) for benznidazole. This is the first drug ever approved by the FDA to treat Chagas disease.
A new edition of the #ChagasChallenge, promoted by Mundo Sano and the multinational pharmaceutical company Chemo Group, has now begun. For the third time, this charity adventure will be supported by the athlete Chema Martinez, who will hang up her running shoes for a few days to cover the 750 kilometres that separate Madrid from the Portuguese capital by bike.